Wuxi Biologics (Cayman) Inc. is a major player in the biotechnology and medical research sector, specializing in providing comprehensive solutions for the discovery, development, and manufacturing of ... Wuxi Biologics (Cayman) Inc. is a major player in the biotechnology and medical research sector, specializing in providing comprehensive solutions for the discovery, development, and manufacturing of biologic drugs. As an investment holding company, it operates through two main business segments. The Biologics segment focuses on end-to-end services that encompass biologics discovery, process development, and large-scale manufacturing. Its WuXi XDC segment delivers contract research, development, and manufacturing organization (CRDMO) services, particularly for antibody-drug conjugates (ADCs) and various bioconjugates, catering to both domestic and international clientele. Headquartered in Wuxi, China, and supported by a workforce of over 12,000 employees, the company plays a critical role in advancing biologics innovation and accelerating drug development for pharmaceutical and biotechnology companies worldwide. Wuxi Biologics (Cayman) Inc.'s business model helps lower the barriers for biopharma firms to bring new therapeutic products to market by offering state-of-the-art technical expertise and integrated solutions throughout the biologics lifecycle.Show lessShow more

Disclosures ESG Data Financial Data

Income Statement Balance Sheet Group Entities

Data not available

Group Entities data not yet covered for WuXi Biologics (Cayman)

We have not yet reviewed WuXi Biologics (Cayman)'s disclosures for Group Entities data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review WuXi Biologics (Cayman)'s data?

Start your 30-day free trial to request a data review for WuXi Biologics (Cayman).

Start Free Trial

Legal Center Contact Us